White matter-associated microglia: New players in brain aging and neurodegenerative diseases

Kyusik Ahn1, Seung-Jae Lee2, Inhee Mook-Jung2

  • 1Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.

Ageing Research Reviews
|January 30, 2022
PubMed

Insights

Brain aging accelerates neurodegeneration and cognitive decline. Senescent white matter-associated microglia (WAM) contribute to axonal loss, suggesting they are key targets for brain rejuvenation strategies.

Area of Science:

  • Neuroscience
  • Aging Research
  • Cellular Biology

Background:

  • Brain aging is a significant risk factor for neurodegenerative diseases like Alzheimer's and can independently cause cognitive decline.
  • Microglia, particularly white matter-associated microglia (WAM), play a crucial role in modulating glial cells and clearing myelin debris during white matter aging.
  • Senescent microglia exhibit impaired phagocytosis and altered lipid metabolism, leading to myelin sheath degeneration and axonal loss.

Purpose of the Study:

  • To review the current understanding of brain aging, focusing on the roles of white matter and microglia.
  • To explore the contribution of senescent white matter-associated microglia (WAM) to axonal loss.
  • To propose potential strategies for rejuvenating the aged brain.

Main Methods:

  • Literature review of studies on brain aging, white matter, and microglia.
  • Analysis of recent findings identifying white matter-associated microglia (WAM) in aged mice.
  • Examination of the functional and metabolic changes in senescent microglia.

Main Results:

  • Identification of a specific subpopulation of microglia, WAM, in the white matter of aged mice.
  • Senescent microglia demonstrate reduced phagocytic capacity and dysregulated lipid metabolism.
  • Accumulation of lipid metabolites due to impaired WAM function contributes to myelin sheath degeneration.

Conclusions:

  • Senescent WAM are implicated as critical mediators of axonal loss during brain aging.
  • Targeting senescent WAM may offer a promising avenue for brain rejuvenation therapies.
  • Further research into WAM function is essential for developing interventions against age-related cognitive decline.

Related Concept Videos